Prostate cancer detection with smarter MRI calibration
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new calibration technology to improve how suspicious spots seen on MRI are targeted during prostate biopsy. It may help men who need a biopsy after an MRI shows a possible cancer area (Likert 3 or higher).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man 18 or older being checked for prostate cancer.
- You have already had a standard prostate MRI as part of your care.
- Your MRI report shows at least one suspicious area (rated Likert 3 or higher).
- You are scheduled to have a targeted biopsy within 6 months of that MRI.
- You do not have a PSA level over 20 in the last 6 months.
- You have never been diagnosed with prostate cancer before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a faster prostate MRI and image-matching (image-fusion) can better find suspicious spots so doctors can target a biopsy. If you have concerning prostate exam results or PSA blood test results, you may get an MRI and, if something looks suspicious, a biopsy using MRI images.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This study tests if a special MRI measurement (ADC) can improve how well a standard MRI finds prostate cancer. If you have a suspicious MRI and are scheduled for a biopsy, this might help better understand your results.
This trial tests whether having repeated MRI scans can help find prostate cancer early in men who have never had a biopsy. It may be a good fit if you have a slightly elevated PSA and a suspicious spot on your first MRI.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
This study tests whether new MRI imaging methods can better identify and grade prostate cancer in men with elevated PSA levels. You would get an MRI scan to help doctors see if cancer is present and how aggressive it might be.
Hear when a new Prostate Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.